VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 0980716
Sex: F
Age:
State: CA

Vax Date: 01/10/2021
Onset Date: 01/10/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Date: 20210115; Test Name: rapid Covid test; Result Unstructured Data: Test Result:Negative; Comments: nasal swab

Allergies:

Symptoms: extreme fatigue; fever 5+ days; headache; diarrhea; This is a spontaneous report from a contactable other healthcare professional (patient herself). A 39-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number EL1283), intramuscular (left arm), on 10Jan2021 13:00, at single dose, for covid-19 immunization. Medical history included allergies: sulfa, venom. Concomitant medications included omeprazole (OMEPRAZEN); duloxetine; cefixime (FLEXERIL); promethazine (PHENERGAN) and; gabapentin. The patient previously took gentamicin and experienced allergies. The patient experienced extreme fatigue, fever 5+ days, headache, diarrhea all on 10Jan2021 at 18:00. These adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received an unspecified treatment for these events. The patient had no other vaccines administered in four weeks and had no Covid prior vaccination. The patient had a rapid Covid test post vaccination via nasal swab on 15Jan2021 with result of negative. The outcome of the events was not recovered.

Other Meds: OMEPRAZEN [OMEPRAZOLE]; DULOXETINE; FLEXERIL [CEFIXIME]; PHENERGAN [PROMETHAZINE]; GABAPENTIN

Current Illness:

ID: 0980717
Sex: F
Age:
State: SC

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Date: 20210115; Test Name: Body temperature; Result Unstructured Data: Test Result:10.5-102.8

Allergies:

Symptoms: Dizziness; headaches; chills while body is on fire/temperatures ranging from 10.5-102.8; This is a spontaneous report from a contactable healthcare professional, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 15Jan2021 at 08:45 (at the age of 33-years-old) as a single dose for COVID-19 immunization. Medical history included aplastic anaemia, gastroparesis, and migraine with aura. The patient did not have any allergies to medications, food, or other products. There were no concomitant medications. The patient previously received the first dose of BNT162B2 on 28Dec2020 at 14:00 (at the age of 33-years-old) in the right arm for COVID-19 immunization. The patient did not receive any other vaccines within four weeks prior to the second vaccination (except the first dose). On 15Jan2021 at 17:00, the patient experienced dizziness, headaches, chills while body was on fire/temperatures ranging from 10.5 (as reported) to 102.8 even with the use of acetaminophen (TYLENOL) or ibuprofen (MOTRIN). The patient did not receive any treatment for the dizziness or headaches. The clinical outcomes of the dizziness, headaches, and chills while body was on fire/temperatures ranging from "10.5-102.8" were not recovered. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 0980718
Sex: F
Age:
State: IN

Vax Date: 01/09/2021
Onset Date: 01/11/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Shortness of breath with activity; night sweats; right jaw pain; This is a spontaneous report from a contactable other healthcare professional (patient). A 41-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3248), intramuscular in the right arm on 09Jan2021 at a single dose for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient's medical history included thyroid cancer. The patient had no known allergies to medications, food, or other products. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. Concomitant medication included paracetamol (TYLENOL). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced shortness of breath with activity, night sweats, and right jaw pain on 11Jan2021. Right jaw pain resulted in physician office visit. No treatment was received for the adverse events. Outcome of the events was not recovered. The events were considered non-serious.

Other Meds: TYLENOL

Current Illness:

ID: 0980719
Sex: F
Age:
State: TX

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: 15hrs post injection, muscle aches, joint pain; 15hrs post injection, muscle aches, joint pain; injection site pain 12hrs post injection; intense chills/shivering 12hrs post injection #2; This is a spontaneous report from a contactable nurse. A 41-year-old non-pregnant female patient received the second dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EL3248 and Expiration Date: Apr2021), via an unspecified route of administration in the left arm on 15Jan2021 at 12:00 at 41-years-old at a single dose for COVID-19 immunization in a hospital. Medical history included asthma from an unknown date and unknown if ongoing, gastrooesophageal reflux disease (GERD) from an unknown date and unknown if ongoing, thoracic outlet syndrome (arterial/neurogenic) from an unknown date and unknown if ongoing, Allergies to Iodine based contrast from an unknown date and unknown if ongoing, sulfonamide allergy from an unknown date and unknown if ongoing. The patient previously received the first dose of the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) for COVID-19 immunization on 28Dec2020 at 12:00 at 41-years-old and experienced no symptoms (first dose; Lot number: EJ1685, EXP: Mar2021, vaccine location: left arm). Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), levocetirizine dihydrochloride (XYZAL), omeprazole (PROTONIX); all taken for an unspecified indication from an unspecified date to an unspecified date; within two weeks of vaccination. On 16Jan2021 at 00:00, the patient experienced: injection site pain 12hrs post injection, intense chills/shivering 12hrs post injection #2. On 16Jan2021 at 03:00, the patient experienced: 15hrs post injection, muscle aches, joint pain. Therapeutic measures were taken as a result of intense chills/shivering 12hrs post injection #2: relieved by 500 mg of paracetamol (TYLENOL) upon onset of chills (as reported). The clinical outcome of the events was recovering (as reported). The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.

Other Meds: GABAPENTIN; XYZAL; PROTONIX

Current Illness:

ID: 0980720
Sex: M
Age:
State: MI

Vax Date: 01/09/2021
Onset Date: 01/10/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Bruising from injection site up to shoulder; This is a spontaneous report from a contactable healthcare professional (reporting for himself). A 55-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EL3246), via an unspecified route of administration in the left arm on 09Jan2021 14:45 at a single dose for COVID-19 immunization. Medical history included multiple sclerosis (MS). Concomitant medication included lisinopril (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced bruising from injection site up to shoulder on 10Jan2021. The patient did not received treatment for the event. The outcome of bruising from injection site up to shoulder was not recovered.

Other Meds: LISINOPRIL

Current Illness:

ID: 0980721
Sex: F
Age:
State: DE

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: about 30-45 minutes later started feeling numbness on left side of face; left lower lip remained slightly numb; This is a spontaneous report from a contactable nurse. A 61-year-old female nurse reported that she received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EJ1686), intramuscular at single dose into the left arm on 08Jan2021 at 03:30 PM for COVID-19 immunization. First dose of BNT162B2 was received on 18Dec2020. Medical history included rheumatoid arthritis, coronary artery disease and hypertension. Past drug history included NSAIDS which caused bleeding. The patient's concomitant medications were not reported. The patient reported that about 30-45 minutes after vaccination she started feeling numbness on left side of face and left lower lip remained slightly numb. The events were reported as non-serious. The patient did not receive any treatment for the events. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 0980722
Sex: F
Age:
State: WV

Vax Date: 01/14/2021
Onset Date: 01/15/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sore L arm; body aches; chills; diarrhea; headache; This is a spontaneous report from a contactable physician (patient). A 45-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EL8982, expiration date unspecified), intramuscular on 14Jan2021 15:30 at single dose (left arm) for Covid-19 immunization. Medical history included vitamin d deficiency (def), Beta Thalassemia, some shellfish allergy, Sulfa allergy and COVID-19, which was prior to vaccination. Concomitant medication included vitamin D3. The patient received vitamin D3 within 2 weeks of vaccination. On 15Jan2021 at 06:45, the patient experienced sore left (L) arm, body aches, chills, diarrhea, and headache. The patient did not received treatment for the events. Facility where the most recent COVID-19 vaccine was administered was at the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and patient had not been tested for Covid-19 since the vaccination. Outcome of events was recovering.

Other Meds: VITAMIN D3

Current Illness:

ID: 0980723
Sex: M
Age:
State:

Vax Date: 01/12/2021
Onset Date: 01/01/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: some injection site tenderness; a really bad head ache; fatigue; joint pain; This is a spontaneous report from a contactable consumer (patient). A 71-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on 12Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient received his first dose 4 days ago and reported some injection site tenderness on 12Jan2021. He stated that 18 hours after his injection he had "a really bad head ache", fatigue, and joint pain for the remainder of the day on Jan2021. Outcome of the events was recovered on Jan2021. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0980724
Sex: F
Age:
State: MN

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; body aches; fever; dizziness; sore arm; drowsiness; loss of balance; agitation; skin ach; This is a spontaneous report from a contactable consumer (patient). A 49-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231 and expiration date not provided), via an unspecified route of administration in the left arm on 15Jan2021 13:30 at a single dose for COVID-19 immunization. Medical history included osteoarthritis, guttate psoriasis, degenerative disc disease, fibromyalgia, COVID, and allergies (unspecified). The patient did not receive any other vaccine in 4 weeks. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medication included unspecified medication. The patient experienced headache, body aches, fever, dizziness, sore arm, drowsiness, loss of balance, agitation, and "skin ach" on 15Jan2021 21:00. Treatment was not provided in response to the events. The patient has not undergone COVID test post vaccination. The outcome of the events was recovered with sequel on an unspecified date in Jan2021.

Other Meds:

Current Illness:

ID: 0980725
Sex: F
Age:
State: NC

Vax Date: 12/29/2020
Onset Date: 12/29/2020
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Date: 20210111; Test Name: Covid test; blood test; antibodies; Test Result: Negative ; Test Name: Covid tested; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptoms: muscles hurt so bad/severe myalgias, muscle aches; couldn't walk; sobbing; pain; fiance had to change her clothes for her; bad oral herpes outbreak; joint pains; malaise; fatigue; This is a spontaneous report from a contactable Physician reported for herself. A 32-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number Eh9899 and expiry date unknown) intramuscular at the left arm on 29Dec2020 09:00 at single dose for Covid-19 immunization in a hospital. Medical history included endometriosis. The patient has no Covid prior vaccination. The patient was not pregnant. Concomitant medications included norethindrone [norethisterone], lifitegrast (XIIDRA), dextromethorphan hydrobromide, guaifenesin, paracetamol, pseudoephedrine hydrochloride (DAYQUIL); all from unspecified date for unspecified indication. The patient informed that the first 24 hours were so severe she almost went to the emergency department. On 12Dec2020: 20:00, her muscles hurt so bad she couldn't walk. The patient was sobbing in pain. Her fiance had to change her clothes for her. The patient got a bad oral herpes outbreak at about 24 hours of vaccination. The patient informed that she got better from this acute phase, however now at 3 weeks out she continued to struggle with joint pains, severe myalgias, muscle aches, malaise and fatigue that was worse with attempted exercise. The patient underwent lab test and procedures which included Covid test/blood test/antibodies: negative on 11Jan2021. The patient was Covid tested post vaccination. The patient did not received treatment due to the events.

Other Meds: NORETHINDRONE [NORETHISTERONE]; XIIDRA; DAYQUIL

Current Illness:

ID: 0980726
Sex: M
Age:
State: NC

Vax Date: 01/09/2021
Onset Date: 01/12/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: hypertension; 1 nosebleed; slight headache; This is a spontaneous report from a contactable nurse. A 32-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot EL0140, expiry date not reported), via an unspecified route of administration on 09Jan2021 09:45 at a single dose in the right arm for COVID-19 immunization. Medical history included known allergies on penicillin as child. The patient had no COVID prior to vaccination. The patient's concomitant medications were not reported. Patient had the first dose of BNT162B2 (Pfizer brand, Lot number: EH9899) on 21Dec2020 08:45 AM in the left arm for COVID-19 immunization. The patient had no other vaccine in four weeks. Patient received second dose 09Jan2021 and for the last 4 days, started on 12Jan2021, the have had hypertension with 1 nosebleed and slight headache with no history of hypertension. No treatments received in response to the events reported. The patient was not tested for COVID post vaccination. The outcome of the events hypertension, nosebleed and slight headache was not recovered.

Other Meds:

Current Illness:

ID: 0980727
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Name: COVID test; Result Unstructured Data: Test Result:Unknown Results; Comments: COVID test close to that time too where they swabbed my nose

Allergies:

Symptoms: Tiredness; Headache; Nausea; Swelling; Feeling unwell; Nose bleed; Coughed up a blood clot; Congestion; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced tiredness, headache, nausea, swelling, feeling unwell, nose bleed, coughed up a blood clot and congestion on an unspecified date. The patient underwent lab tests and procedures which included sars-cov-2 test: unknown results on COVID test close to that time too where they swabbed my nose. Details were as follows: patient got the vaccine on 19th (month and year unspecified), and the COVID test with unknown results close to that time, where they swabbed her nose. She has had had tiredness, headache, nausea, swelling, feeling unwell, and the last night she had a nose bleed and coughed up a blood clot out of her throat. She also had a lot of congestion since taking the injection, and did not know if it was from the injection or the COVID Test. The outcome of tiredness, headache, nausea, swelling, feeling unwell, nose bleed, coughed up a blood clot and congestion was unknown. The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.

Other Meds:

Current Illness:

ID: 0980728
Sex: F
Age:
State: FL

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever 102; chills; headache; joint pain; fatigue; This is a spontaneous report from a contactable other healthcare professional (patient). A 50-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EL1284, expiration date not reported) via an unspecified route of administration on the left arm on 11Jan2021 11:00 at a single dose for COVID-19 immunization. The patient had no medical history. The patient's concomitant medications were not reported. The patient previously received 1st dose of BNT162B2 on 21Dec2020 for COVID-19 immunization. On 11Jan2021 at 09:00 PM, the patient experienced fever 102, chills, headache, joint pain, and fatigue for 2 days. No treatment was received for the events. The facility where the vaccine was administered was in a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There were no other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. No known allergies. Outcome of the events was recovered in Jan2021.

Other Meds:

Current Illness:

ID: 0980729
Sex: F
Age:
State: TN

Vax Date: 12/22/2020
Onset Date: 12/22/2020
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: slight discomfort at the site of injection; occasional soreness at the site of injection; This is a spontaneous report from a contactable physician reporting for herself. A 76-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), intramuscular in left arm on 22Dec2020 12:00 at single dose for COVID-19 immunization. Medical history included high cholesterol from an unknown date and unknown if ongoing. Concomitant medication included atorvastatin, calcium, ibuprofen, estrogens conjugated (PREMARIN), ergocalciferol (VIT D) and multivit (as reported). The patient was not pregnant. For vaccine dose 1, it was reported that the patient experienced slight discomfort at the site of injection and occasional soreness at the site of injection over on 22Dec2020. No treatment was given to the patient for the events. The outcome of the events was recovered on unspecified date. The facility where the most recent COVID-19 vaccine was administered was in the Health Clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.

Other Meds: ATORVASTATIN; CALCIUM; IBUPROFEN; PREMARIN; VIT D

Current Illness:

ID: 0980730
Sex: F
Age:
State: NC

Vax Date: 01/13/2021
Onset Date: 01/14/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Date: 20210114; Test Name: Body Temperature; Result Unstructured Data: Test Result:101; Comments: 01:00

Allergies:

Symptoms: Fever 101; pain in both thigh; chills; nausea; headache; This is a spontaneous report from a contactable nurse (patient herself). A 61-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140, expiry date not reported), via an unspecified route of administration in the left arm on 13Jan2021 13:00 at single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS). Concomitant medications were none. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was vaccinated at a hospital. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient had no allergies to medications, food, or other products. On 14Jan2021 01:00, the patient experienced fever 101, pain in both thighs, chills, nausea and headache. No treatment was received for the adverse events. Clinical outcome of the events was recovered with sequelae on Jan2021.

Other Meds:

Current Illness:

ID: 0980731
Sex: F
Age:
State: GA

Vax Date:
Onset Date:
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: swollen lymph nodes; lymph nodes were swollen, it was very painful; This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was reporting swollen lymph nodes following administration of the second dose of the Pfizer-Biontech Covid19 vaccine. Her lymph nodes were swollen, it was very painful. It was near her collar bone, near her shoulder. She never had this before, so she was asking for some advice. Outcome of the events was unknown. Information on the Lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0980732
Sex: M
Age:
State: NC

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Very light soreness at injection site; This is a spontaneous report from a contactable consumer. A 73-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: E13248), via an unspecified route of administration from 16Jan2021 at 09:15 on his right arm at a single dose for COVID-19 immunization. Medical history included hypertension (successfully controlled with 10 mg lisinopril) from an unknown date and unknown if ongoing. Concomitant medications included fish oil, glucosamine and lisinopril. The patient experienced very light soreness at injection site on 16Jan2021 at 10:00. The patient did not receive treatment for the event. The outcome of the event was unknown.

Other Meds: FISH OIL; GLUCOSAMINE; LISINOPRIL

Current Illness:

ID: 0980733
Sex: F
Age:
State: TN

Vax Date: 01/13/2021
Onset Date: 01/16/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Rash on both arms and stomach; This is a spontaneous report from a contactable other healthcare professional (HCP) (patient). A 68-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0142, expiration date: unknown), intramuscular (left arm) on 13Jan2021 at 01:45 at a single dose for COVID-19 immunization. Medical history included known allergies. The patient is not pregnant. Concomitant medications were not reported. The patient had no other vaccine in four weeks. The patient had no COVID prior vaccination and had not tested post-vaccination. The patient experienced rash on both arms and stomach on 16Jan2021 at 09:30. No treatment administered for the event. The event had not resolved.

Other Meds:

Current Illness:

ID: 0980734
Sex: F
Age:
State: MI

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swollen lymph nodes in left armpit; This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number: ELI283, via an unspecified route of administration on Left Arm from 07Jan2021 14:45 to 07Jan2021 14:45 as SINGLE DOSE for COVID-19 immunisation. Medical history included none. The patient's concomitant medications were not reported. The patient experienced Swollen lymph nodes in left armpit on 08Jan2021 12:00 with outcome of not recovered. The patient is not pregnant. Patient was not tested for COVID prior and post vaccination. No treatment was received for the event.

Other Meds:

Current Illness:

ID: 0980735
Sex: F
Age:
State: MA

Vax Date: 01/14/2021
Onset Date: 01/16/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever; chills; myalgia; large left axillary lymphadenopathy; This is a spontaneous report from a contactable physician (patient). A 32-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number EJ1686), intramuscular at left arm on 14Jan2021 12:00 at single dose for COVID-19 immunization at a hospital. There was no known allergies, no other medical history. There were no concomitant medications, the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not receive any other medications within 2 weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number EJ1685), intramuscular at left arm on 23Dec2020 12:00 for COVID-19 immunization at a hospital. The patient had no COVID prior to vaccination, and had not been tested for COVID since the vaccination. It was reported that on 16Jan2021 01:00, the patient experienced fever, chills, myalgia and large left axillary lymphadenopathy. No treatment was received for the events. The outcome of the events was reported as "recovered with lasting effects".

Other Meds:

Current Illness:

ID: 0980736
Sex: F
Age:
State: TN

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swollen axillary lymph node on same side as injection; fatigue; body aches; headache; injection site soreness; This is a spontaneous report from a contactable nurse. A 49-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL3302), via an unspecified route of administration in left arm on 13Jan2021 00:15 at a single dose for COVID-19 immunization. Vaccination was done in a hospital. Medical history included asthma, anxiety and penicillin allergy. The patient did not have COVID prior to vaccination. Concomitant medication included escitalopram oxalate (LEXAPRO), cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), zinc (ZINC), vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]), and montelukast sodium (SINGULAIR). The patient previously received the first dose of bnt162b2 (lot number EL1284) on 23Dec2020 12:00 PM in left arm for COVID-19 immunization. The patient experienced swollen axillary lymph node on same side as injection, fatigue, body aches, headache, injection site soreness on 13Jan2021 20:00. The outcome of the events was recovering. No treatment was received for the events. The patient was not tested for COVID-19 post vaccination.

Other Meds: LEXAPRO; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; ZINC; VITAMIN C [ASCORBIC ACID]; SINGULAIR

Current Illness:

ID: 0980737
Sex: F
Age:
State: OK

Vax Date: 01/09/2021
Onset Date: 01/01/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Injection site pain; Body aches; This is a spontaneous report from a contactable nurse (reporting for self). A 37-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number EL1283, intramuscularly on 09Jan2021 as a single dose (Dose 2), for COVID-19 immunization. Medical history included depression. The patient had not experienced COVD prior to vaccination. The patient had no known allergies. Concomitant medication included bupropion hydrochloride (WELLBUTRIN). The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number EK5730 as a single dose (Dose 1) on 09Jan202110:00 right arm, for COVID-19 immunization. There was no other vaccine administered in the 4 weeks prior to the COVI-19 vaccination. There was no reaction with the 1st dose. With the 2nd dose, the patient experienced injection site pain and body aches for 24 hours, onset Jan2021. There was no treatment received for the event. The outcome of the events injection site pain and body aches was recovered in Jan2021.

Other Meds: WELLBUTRIN

Current Illness:

ID: 0980738
Sex: F
Age:
State: CA

Vax Date: 12/27/2020
Onset Date: 01/01/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Date: 20210109; Test Name: COVID-19 oral swab test by curative; Test Result: Negative

Allergies:

Symptoms: Left side lymph node supraclavicular swollen; This is a spontaneous report from a contactable consumer (patient). A 38-year-old female patient (non-pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EH9899), via an unspecified route of administration in left arm, on 27Dec2020 at 11:00, at a single dose, for COVID-19 immunization. The patient's medical history included irritable bowel syndrome (IBS), and human papilloma virus (HPV-16). The patient's concomitant medication included plecanatide (TRULANCE). The patient had no known allergies. The patient was not diagnosed with COVID-19 prior vaccination. No other vaccine was administered in four weeks. The vaccine was administered in a public health clinic or veteran's administration facility. On 01Jan2021 at 08:00 AM, the patient experienced left side lymph node supraclavicular swollen 5 days after the injection. The event resulted in doctor or other healthcare professional office or clinic visit. At the time of reporting, it is still enlarged. It was unknown if treatment was given for the event. The patient underwent COVID-19 oral swab test by curative post-vaccination on 09Jan2021 that was negative. The patient had not recovered from the event.

Other Meds: TRULANCE

Current Illness:

ID: 0980739
Sex: F
Age:
State: FL

Vax Date: 12/29/2020
Onset Date: 01/06/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: Heart rate; Result Unstructured Data: Test Result:shot up to 120s; Comments: Around 9 PM my heart rate shot up to 120s; Test Date: 20210107; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative

Allergies:

Symptoms: chills; heart rate shot up to the 120's; chest pressure; felt like I couldn't breathe every time I stood up; This is a spontaneous report from a contactable nurse (patient). A 42-years-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899, expiration date: unknown), intramuscular on the right arm on 29Dec2020 at 09:30 at a single dose for COVID-19 immunization. Medical history included occasional premature ventricular contractions (PVCs) and high blood pressure. The patient had no known allergies, is not pregnant and had no COVID prior vaccination. Concomitant medications included vitamin C [Ascorbic Acid] (VITAMIN C [ASCORBIC ACID]), vitamin D3 (VITAMIN D3), bromelains (BROMELAIN), quercetin (QUERCETIN), zinc (ZINC), acetylcysteine (NAC [ACETYLCYSTEINE]) and Probiotic. The patient had no other vaccines in four weeks. On 06Jan2021 at 21:00, the patient experienced chills all day but no fever. Around 9pm, her heart rate shot up to the 120s and she had chest pressure and felt like she couldn't breathe every time she stood up. When she laid down, it was better. These lasted about 3 hours. She had some very mild shortness of breath twice after this on the 7th and 9th, but it was not nearly as bad as on the 6th. The patient did not take any medication when these happened. The patient tested for COVID post-vaccination (07Jan2021) through COVID-19 PCR (Nasal Swab) which resulted negative. The events resulted in doctor or other healthcare professional office/clinic visit. No treatment was administered for the events. The events resolved on an unknown date in Jan2021.

Other Meds: VITAMIN C [ASCORBIC ACID]; VITAMIN D3; BROMELAIN; QUERCETIN; ZINC; NAC [ACETYLCYSTEINE]

Current Illness:

ID: 0980740
Sex: F
Age:
State: PA

Vax Date: 01/15/2021
Onset Date:
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Numbness of pinky and ring finger; This is a spontaneous report from a contactable other healthcare professional (patient). A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number not reported, via an unspecified route of administration from 15Jan2021 06:30 to 15Jan2021 06:30 as SINGLE DOSE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced numbness of pinky and ring finger on an unspecified date with outcome of unknown. Therapeutic measures were taken as a result of numbness of pinky and ring finger which includes prednisone. The patient is not pregnant. The patient was not tested with COVID prior and post vaccination. Information on the Batch/Lot number has been requested.

Other Meds:

Current Illness:

ID: 0980741
Sex: F
Age:
State: WI

Vax Date: 01/14/2021
Onset Date: 01/15/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; moderate joint and muscle pain; muscle pain; This is a spontaneous report from a contactable other healthcare professional (HCP) reporting for herself. A 51-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at left arm on 14Jan2021 12:45 at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Clinic/Administration facility. Medical history included High blood pressure, fibromyalgia, psoriatic arthritis. Patient was not pregnant. Concomitant medications included lisinopril, cyanocobalamin (B12), pyridoxine hydrochloride (B6) and Multivitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced Headache and moderate joint and muscle pain lasting 16-18 hours on 15Jan2021 06:00, treated with 800 mg ibuprofen every 4-6 hours. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was recovered on 15Jan2021. Information on the lot/batch number has been requested.

Other Meds: LISINOPRIL; B12 [CYANOCOBALAMIN]; B6

Current Illness:

ID: 0980742
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: severe allergies; Stuffed up nose; scratchy throat; This is a spontaneous report from a contactable consumer reported that a female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had the first dose and had severe allergies. She had three different reactions since the shot, stuffed up nose and scratchy throat. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0980743
Sex: M
Age:
State: WV

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; Fatigued; Swollen Lymph Nodes; Chills; Nausea; Feeling Unwell; Body Aches; This is a spontaneous report from a contactable consumer (patient himself). An adult male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number EL8982), via an unspecified route of administration (right arm), on 14Jan2021, at single dose, for covid-19 immunization. Medical history included hypertension. The patient's concomitant medications were not reported. The patient experienced headache, fatigued, swollen lymph nodes, chills, nausea, feeling unwell, and body aches - all on 14Jan2021. The patient had none of these symptoms prior to the shot. The patient had no Covid prior vaccination, had no other vaccine in four weeks, and had not been Covid-tested post vaccination. The patient was recovering from the events. No treatment was received for the events reported.

Other Meds:

Current Illness:

ID: 0980744
Sex: F
Age:
State: KS

Vax Date: 01/09/2021
Onset Date: 01/15/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swollen lymph nodes under both armpits; This is a spontaneous report from a contactable healthcare professional (patient). A 34-year-old female patient (non-pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EK9231), intramuscular in left arm, on 09Jan2021 at 10:30, at a single dose, for COVID-19 immunization. The patient's medical history was not reported. The patient's concomitant medications included ibuprofen and lorazepam. The patient previously took the first dose of BNT162B2 (Lot Number: EK5730) on 18Dec2020 at 06:30 PM (intramuscular in right arm) for COVID-19 immunization. The patient was not diagnosed with COVID-19 prior vaccination. No other vaccine was administered in four weeks. The vaccine was administered in a hospital facility. On 15Jan2021 at 12:00 AM, the patient experienced swollen lymph nodes under both armpits a week after administration of the vaccine. It was unknown if treatment was given for the adverse event. The patient has not been tested for COVID-19 post-vaccination. The patient was recovering from the event.

Other Meds: IBUPROFEN; LORAZEPAM

Current Illness:

ID: 0980745
Sex: F
Age:
State: NY

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache - still continuing; Felt fever - like - for 3 days; This is a spontaneous report from a contactable consumer (patient). A 71-years-old female patient received BNT162B2 (lot number: EL3246) via an unspecified route of administration on 11Jan2021 10:00 at single dose for COVID-19 immunisation. Medical history included controlled diabetes. The patient was allergic to Penicillin. Concomitant medication included metformin, atorvastatin (LIPITOR), lisinopril, and Multivitamin. On 11Jan2021, the patient experienced headache - still continuing, this is the 5th day after the vaccination. On 11Jan2021, the patient also had felt fever - like - for 3 days. The patient received Advil as treatment. The patient is not pregnant. Events outcome was not recovered.

Other Meds: METFORMIN; LIPITOR [ATORVASTATIN]; LISINOPRIL

Current Illness:

ID: 0980746
Sex: M
Age:
State: MO

Vax Date: 01/13/2021
Onset Date: 01/14/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Rash on opposite chest and upper limb of injection; Behaves and looks like shingles; This is a spontaneous report from a contactable healthcare professional (patient). A 25-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), intramuscular on the left arm, on 13Jan2021 09:00 at a single dose for COVID-19 immunization. There were no medical history and concomitant medications. The patient experienced rash on opposite chest and upper limb of injection which behaves and looks like shingles but not officially diagnosed on 14Jan2021 12:00. Outcome of the events was not recovered. No treatment was received for the events. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. Information about batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 0980747
Sex: M
Age:
State: MI

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever; chills; nausea; vomiting; diarrhea; sore arm; This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249), via an unspecified route of administration at right arm on 15Jan2021 16:00 at single dose for COVID-19 immunization. Medical history included COVID prior to vaccination. The patient has no known allergies. The patient's concomitant medications were not reported. The patient experienced fever, chills, nausea, vomiting, diarrhea, and sore arm on 16Jan2021. No treatment was received for the events. The patient was not tested for COVID post vaccination. The patient was recovering from the events.

Other Meds:

Current Illness:

ID: 0980748
Sex: F
Age:
State: CA

Vax Date: 01/11/2021
Onset Date: 01/14/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Date: 20201225; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Positive

Allergies:

Symptoms: Dizziness and lightheadedness on day 3-5 after second dose.; This is a spontaneous report from a contactable nurse (patient). A 43-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number and expiration date: unknown), via an unspecified route of administration (right arm) on 11Jan2021 at 12:15 at a single dose for COVID-19 immunization. Medical history included COVID prior vaccination, known since 25Dec2020 and unknown if ongoing. The patient had no known allergies. The patient is not pregnant. There were no concomitant medications. The patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunization on an unspecified date. The patient had no other vaccine in four weeks and no other medications in two weeks. The patient experienced dizziness and lightheadedness on day 3-5 after the second dose on 14Jan2021 at 0900. No treatment administered for the event. The event was resolving. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0980749
Sex: F
Age:
State: OK

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: headaches; achy feeling; nausea; felt hot; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot EL3249) via an unspecified route of administration in the left arm on 12Jan2021 09:15 AM at a single dose for COVID vaccine. Medical history included rheumatoid arthritis. Concomitant medications included leflunomide, paroxetine, and ergocalciferol (VITAMIN D) (other medications in two weeks). The patient had no other vaccine in four weeks. The patient had known allergies to sulfamethoxazole/trimethoprim (SEPTRA) and mefloquine. It was reported that the patient had 4 days of headaches and achy feeling on 12Jan2021. During her 30-minute wait after the injection, she experienced some nausea and felt hot on 12Jan2021. Treatment was not received for the events. The patient had no COVID prior vaccination. She did not have COVID tested post vaccination. The outcome of the events was recovering.

Other Meds: LEFLUNOMIDE; PAROXETINE; VITAMIN D [ERGOCALCIFEROL]

Current Illness:

ID: 0980750
Sex: F
Age:
State: NM

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: The only thing I have with the first injection is soreness at injection site; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number: EL3248, via unspecified route of administration in the left arm on 15Jan2021 (15:30) at single dose for COVID-19 immunization. Patient medical history included high blood pressure (HBP). Concomitant medications included latanoprostene bunod (VYZULTA 0.024%), losartan at 25 mg, and oxybutynin (5 mg ER) for unspecified indications. Patient is not pregnant at the time of vaccination. The patient reported that the only adverse event she had after first injection was soreness at injection site on 15Jan2021 at 3:30 pm. No treatment was received for the event. Outcome of the event was recovered on unspecified date in Jan2021.

Other Meds: VYZULTA; LOSARTAN; OXYBUTYNIN

Current Illness:

ID: 0980751
Sex: F
Age:
State:

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Name: heart rate; Result Unstructured Data: Test Result:usually 80-90 at rest; Test Date: 20210116; Test Name: heart rate; Result Unstructured Data: Test Result:130

Allergies:

Symptoms: elevated heart rate at rest. It's usually 80-90 at rest and now it's 130 and it's been like this for 2 to 3 hours.; received other vaccine at first dose in right arm on the same date; This is a spontaneous report from a non-contactable consumer (patient). A 23-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, unknown lot number and expiration), via an unspecified route of administration in right arm on 15Jan2021 at 12:00 PM at a single dose for COVID-19 immunization. Medical history reported as none. The patient has no known allergies. The patient also received other vaccine at first dose in right arm on the same date. On 16Jan2021 at 05:00 PM (17:00), the patient experienced elevated heart rate at rest. It's usually 80-90 at rest and now it's 130 and it's been like this for 2 to 3 hours. The patient did not receive treatment for the event. The patient has no COVID prior to vaccination and was not tested for COVID post vaccination. The patient had not yet recovered from the event elevated heart rate at rest. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0980752
Sex: F
Age:
State: AZ

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sore arm; swelling in arm; fatigue; This is a spontaneous report from a contactable consumer (patient). An 87-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EL0142), via an unspecified route of administration on 13Jan2021 12:30 PM at single dose on the right arm for COVID-19 immunization. Patient is not pregnant. Medical history included bad back and bad left knee. Concomitant medication included unspecified drug (reported as "Other medications in two weeks: Yes"). The patient previously took Levaquin and experienced allergies. Facility type vaccine was hospital. No other vaccines in four weeks. No COVID prior vaccination. The patient experienced sore arm, swelling in arm and fatigue for 24 hours after the shot on 13Jan2021 12:30 PM. Slowly dissipated over next 24 hours. All adverse events went away after 48 hours. No treatment for the events. Patient was not tested for COVID post vaccination. Outcome of the events was recovered on 15Jan2021 12:30.

Other Meds:

Current Illness:

ID: 0980753
Sex: M
Age:
State: CA

Vax Date: 01/13/2021
Onset Date: 01/14/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Diarrhea; Swelling on the lower Lip and left facial area; Swelling on the lower Lip and left facial area; This is a spontaneous report from a contactable consumer (patient). A 74-year-old male received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL1283 and expiry date: unknown), via an unspecified route of administration on the left arm, on 13Jan2021 16:30 at a single dose for COVID-19 immunization. Medical history included asthma, sinus and sensitive to egg white and milk. Concomitant medication included simvastatin, losartan and syzygium jambolanum. The patient experienced diarrhea, swelling on the lower lip and left facial area on 14Jan2021 09:00. Outcome of the events was recovering. No treatment was received for the events. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.

Other Meds: SIMVASTATIN; LOSARTAN; SYZYGIUM JAMBOLANUM

Current Illness:

ID: 0980754
Sex: F
Age:
State:

Vax Date: 01/13/2021
Onset Date:
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swollen painful lymph nodes in same side of neck and in arm of injection; Swollen painful lymph nodes in same side of neck and in arm of injection; This is a spontaneous report from a contactable pharmacist (patient). A 65-year-old female patient (non-pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), via an unspecified route of administration, the first dose on 23Dec2020 at 10:00 AM, and the second dose on 13Jan2021 at 10:00 AM in right arm, both at a single dose, for COVID-19 vaccination. The patient had no medical history. The patient's concomitant medication included acetylsalicylic acid (ASPIRIN). The patient had no known allergies. The patient was not diagnosed with COVID-19 prior vaccination. No other vaccine was administered in four weeks. The vaccine was administered in a hospital facility. On an unspecified date, the patient experienced swollen painful lymph nodes in same side of neck and in arm of injection. No treatment was administered for the events. The patient has not been tested for COVID-19 post-vaccination. The patient was recovering from the events. No follow-up attempts are possible; information about batch number cannot be obtained. No further information is expected.

Other Meds: ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness:

ID: 0980755
Sex: F
Age:
State:

Vax Date: 01/04/2021
Onset Date: 01/09/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Date: 20210109; Test Name: Fever; Result Unstructured Data: Test Result:under 100; Test Date: 20210115; Test Name: Fever; Result Unstructured Data: Test Result:101.5; Test Date: 20210116; Test Name: Fever; Result Unstructured Data: Test Result:103.8; Comments: worse today

Allergies:

Symptoms: Bad fever/ Fever was under 100/ last night temperature was 101.5 and today 103.8/ worse today; Chills; Fatigue; Muscle pain; Severe diarrhea; Abdominal cramping; This is a spontaneous report from a contactable consumer who reported for herself, a female patient of an unspecified age (reported as 48, unspecified units) who received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiration date unknown), via an unspecified route of administration on 04Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient stated she got the vaccine on 04Jan2021. Patient was experiencing bad fever, chills, fatigue, muscle pain, severe diarrhea and abdominal cramping. Patient did not know if manufacturer could help her with the side effects because her doctor was closed. Patient has experienced all the symptoms since Saturday, 09Jan2021. Fever was under 100 from 09Jan2021 until 15Jan2021 and last night (15Jan2021) temperature was 101.5 and today, 16Jan2021, 103.8. Patient stated worse today. Patient has taken Tylenol. The outcome of bad fever was not recovered, while outcome of the remaining events was unknown. Information on Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0980756
Sex: M
Age:
State: SC

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Chills; Slight headache; This is a spontaneous report from a contactable consumer (patient). A 24-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK9231), via an unspecified route of administration on the left arm on 15Jan2021 at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient had no known allergies, did not have COVID prior to vaccination, did not receive other vaccines four weeks prior, did not receive other medications in two weeks of vaccination, and was vaccinated at a hospital. On 16Jan2021 13:15, the patient experienced chills and slight headache. No treatment was received for the events. The patient has not been tested for COVID post-vaccination. Outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0980757
Sex: F
Age:
State: IL

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sore arm; very tired; fever; This is a spontaneous report from a contactable other healthcare professional reporting for herself. A 66-year-old female patient received the first dose of bnt162b2 (BNT162B2, lot number EL3246, expiry date: not reported), via an unspecified route of administration, on 15Jan2021 04:45 AM at a single dose on the left arm for COVID-19 immunization. Facility type vaccine was Other. The patient was not pregnant. The patient did not receive other vaccines in four weeks. She had no other medications in two weeks. The patient did not have covid prior to vaccination and was not tested for covid post vaccination. Medical history included known allergies: PCN (penicillin). Concomitant medications were none. The next day, on 16Jan2021 02:15 PM, the patient experienced sore arm, very tired and fever. The patient took Tynol in response to the adverse events. Outcome of the events was recovered on an unspecified date in Jan2021.

Other Meds:

Current Illness:

ID: 0980758
Sex: F
Age:
State: AL

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Nausea; light headed; This is a spontaneous report from a contactable consumer (patient). A 25-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number: EL3246, via unspecified route of administration in the right arm on 16Jan2021 13:45 at single dose for COVID-19 immunization. Patient medical history included allergy to dairy (milk allergy) and wheat. Concomitant medications were not reported. Patient is not pregnant at the time of vaccination. On 16Jan2021 at 14:30, the patient experienced nausea and light headed. No treatment received for the events. Outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 0980759
Sex: M
Age:
State: NJ

Vax Date:
Onset Date:
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Patient said he felt flu like symptoms for first day and started to ween off after the second and third day; This is a spontaneous report from a contactable physician reported for self via Pfizer sales representative. This male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number unknown) via unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (Lot number unknown) on an unspecified date at single dose for COVID-19 immunisation. The patient mentioned that he had severe side effects after taking the second dose COVID 19 vaccine. Patient said he felt flu like symptoms for first day and started to ween off after the second and third day. Event took place after use of product. The patient was resolving. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0980760
Sex: M
Age:
State: PA

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Upper Stomach pain; Pain at injection site; Fatigue; This is a spontaneous report from a contactable pharmacist. A 59-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot EL3248, expiry date not reported), intramuscular on 15Jan2021 13:30 at a single dose in the left arm for COVID-19 immunization. Medical history included diabetes, HBP (high blood pressure), and cholesterol. The patient had no allergies. The patient had no covid prior to vaccination. The patient's concomitant medications were not reported. The patient had no other vaccine in four weeks. On 16Jan2021, the patient experienced upper stomach pain, pain at injection site, and fatigue. Therapeutic measures were taken as a result of the events reported which included esomeprazole 40mg and rantidine 150mg. The patient was not tested for covid post vaccination. The outcome of events upper stomach pain, pain at injection site, and fatigue was recovering.

Other Meds:

Current Illness:

ID: 0980761
Sex: F
Age:
State:

Vax Date: 12/30/2020
Onset Date: 01/14/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Date: 20210114; Test Name: Covid; Test Result: Positive ; Test Date: 20210116; Test Name: Covid; Test Result: Negative

Allergies:

Symptoms: Tested positive for Covid; Tested positive for Covid; This is a spontaneous report from a non-contactable consumer. This (age: 56, unit: unknown) female consumer (patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via unspecified route on 30Dec2020 at single dose for COVID-19 immunization. Medical history and concomitant drugs were not reported. Patient was tested positive for Covid today, 14Jan2021. She was scheduled to get her next dose 20Jan2021. She had no symptoms. She received a negative Covid test result yesterday (16Jan2021). She would be quarantining for 2 weeks. Outcome of events was unknown. No follow-up attempts are possible; Information about Lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0980762
Sex: M
Age:
State:

Vax Date: 12/23/2020
Onset Date: 12/23/2020
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; fatigue; irritable bowels; diarrhea; nausea; stomach cramps/stomach pain; arm soreness; kidney pain; the first dose of BNT162B2 was administered in the left leg; This is a spontaneous report from a non-contactable pharmacist, the patient. A 29-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1284), via an unspecified route of administration in the left leg on 23Dec2020 at 13:00 (at the age of 29-years old) as a single dose for COVID-19 immunization. Medical history included gastrooesophageal reflux disease. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Jan2021 at 15:00, the patient experienced headache, fatigue, irritable bowels, diarrhea, nausea, stomach cramps/stomach pain, arm soreness, and kidney pain. The patient took lopearmde (MANUFACTURER UNKNOWN), sucralafate (MANUFACTURER UNKNOWN), and calcium carbonate (TUMS) as treatment. The clinical outcomes of the headache, fatigue, irritable bowels, diarrhea, nausea, stomach cramps/stomach pain, arm soreness, and kidney pain were not recovered. It was reported that the patient received the second dose of the BNT162B2 on 11Jan2021 (at the age of 29-years old; Lot Number: EL3302) in the right arm. No follow-up attempts are possible. No further information is expected.

Other Meds: OMEPRAZOLE

Current Illness:

ID: 0980763
Sex: F
Age:
State: IL

Vax Date: 01/12/2021
Onset Date: 01/13/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data: Test Date: 20210113; Test Name: Body temperature; Result Unstructured Data: Test Result:101.4; Comments: fever up to 101.4

Allergies:

Symptoms: Headache; fatigue; chills; nausea; vomiting; fever up to 101.4; sweating; This is a spontaneous report from a contactable other hcp. A 40-year-old female patient received their second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL3248, expiry date not reported) via an unspecified route of administration on the right arm on 12Jan2021 03:45 at single dose for COVID-19 immunization. Medical history included migraine and acid reflux from an unknown date and unknown if ongoing. The patient has no known allergies. Concomitant medication included pantoprazole for acid reflux. The patient received their first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EJ1685, expiry date not reported) on 22Dec2020 on the right arm for COVID-19 immunization. The patient experienced headache, fatigue, chills, nausea, vomiting, fever up to 101.4 and sweating on 13Jan2021 12:00. The patient underwent lab tests and procedures which included body temperature: 101.4 on 13Jan2021. The patient recovered from the events on an unspecified date. No treatment was given in response to the events. The patient had no COVID prior to vaccination and has not COVID tested post vaccination.

Other Meds: PANTOPRAZOLE

Current Illness:

ID: 0980764
Sex: F
Age:
State:

Vax Date: 01/15/2021
Onset Date: 01/01/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sensitize teeth; diarrhea; nausea; This is a spontaneous report from a contactable nurse. A 45-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date unknown), via an unspecified route of administration, on 15Jan2021, at single dose, for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry date unknown) for covid-19 immunization on an unspecified date. The patient got her 2nd COVID19 Vaccine dose yesterday 15Jan2021 and, she asked if it was normal to have really sensitize teeth (started last night, 15Jan2021) and that, she also experienced diarrhea and nausea both in Jan2021. The outcome of the events was unknown. Information about the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0980765
Sex: F
Age:
State: TN

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 01/28/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Chills; generalized muscle cramping especially in back and chest; site pain; This is a spontaneous report from a contactable other HCP. A 24-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3302), via an unspecified route of administration on arm left from 16Jan2021 08:30 to 16Jan2021 08:30 at SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date. On 16Jan2021 at 20:00, the patient experienced chills, generalized muscle cramping especially in back and chest and site pain. The patient was not pregnant at the time of the report. Outcome of the events was recovering. .

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm